Olaris to Present Results from Three Studies Showcasing Non-Invasive Urine Assays for Graft Injury Detection and Drug Compliance at 2025 World Transplant Congress
Olaris will highlight data demonstrating the power of its myOLARIS™-KTdx urine-based diagnostic to detect and differentiate kidney graft injury with high accuracy. These findings represent a major step toward enabling non-invasive, real-time monitoring to improve long-term outcomes for transplant recipients....







